Web Results

law.justia.com/cases/federal/appellate-courts/cadc/16-5356/16-5356-2018-06-19.html

Jun 19, 2018 ... Therefore, all of the communications were protected by the ... FTC v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 16-5356 (D.C. Cir. 2018).

law.justia.com/cases/federal/district-courts/pennsylvania/pawdce/2:2017cv01153/240814/20

Feb 15, 2018 ... BELL v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al, No. 2: 2017cv01153 - Document 20 (W.D. Pa. 2018) case opinion from ...

www.cadc.uscourts.gov/internet/opinions.nsf/A81BAEEA3D756416852582B100518ADF/$file/16-5356.pdf

Jun 19, 2018 ... Boehringer Ingelheim Pharmaceuticals, Inc. Warren D. ... alleged infringer, rather than the other way around.” FTC v. Actavis, Inc., 570 U.S. 136, 141 (2013). .... All of those communications are protected by the attorney-client ...

www.law360.com/cases/59820bc59c43e06ea0000001

Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from Delaware Court. ... Pharma Cases To Watch In 2018's Home Stretch. Drugmakers ...

www.law360.com/cases/5b6df7e75ff24a28265f1bff

Parties, docket activity and news coverage of federal case BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al ...